Results
1 -
10 of
161
(Click
here to explore results)
- Metabolic profiling study of shikonin's cytotoxic activity in the Huh7 human hepatoma cell line. E. D. Spyrelli, A. V. Kyriazou, C. Virgiliou, A. Nakas, O. Deda, V. P. Papageorgiou, A. N. Assimopoulou, H. G. Gika
, Mol. BioSyst.
, 2017
, 13
, 841
- Design, synthesis and biological evaluation of shikonin thio-glycoside derivatives: new anti-tubulin agents. Hong-Yan Lin, Hong-Wei Han, Li-Fei Bai, Han-Yue Qiu, De-Zheng Yin, Jin-Liang Qi, Xiao-Ming Wang, Hong-Wei Gu, Yong-Hua Yang
, RSC Adv.
, 2014
, 4
, 49796
- Modeling of hyperbranched polyesters as hosts for the multifunctional bioactive agent shikonin. I. Tanis, K. Karatasos, A. N. Assimopoulou, V. P. Papageorgiou
, Phys. Chem. Chem. Phys.
, 2011
, 13
, 10808
- Box–Behnken designed adsorption based elution – unique separation process for commercially important acetyl shikonin from Arnebia nobilis. Shankar Subramaniam, Anbumathi Palanisamy, Aravind Sivasubramanian
, RSC Adv.
, 2015
, 5
, 6265
- Excited state deactivation mechanisms in Shikonin rationalized from its naphthoquinone parent structures. Catarina M. Pinto, João Pina, Estefanía Delgado-Pinar, J. Sérgio Seixas de Melo
, Phys. Chem. Chem. Phys.
, 2022
, 24
, 20348
- Electrochemical and theoretical analysis of the reactivity of shikonin derivatives: dissociative electron transfer in esterified compounds. Georgina Armendáriz-Vidales, Carlos Frontana
, Org. Biomol. Chem.
, 2014
, 12
, 6393
- Design, synthesis and mechanism of novel shikonin derivatives as potent anticancer agents. Shahla Karim Baloch, Lin Ma, Xue-Liang Wang, Jing Shi, Yu Zhu, Feng-Yao Wu, Yan-Jun Pang, Gui-Hua Lu, Jin-Liang Qi, Xiao-Ming Wang, Hong-Wei Gu, Yong-Hua Yang
, RSC Adv.
, 2015
, 5
, 31759
- Acetyl shikonin induces IL-12, nitric oxide and ROS to kill intracellular parasite Leishmania donovani in infected hosts. Mamilla R. Charan Raja, Sujatha Srinivasan, Shankar Subramaniam, Narendran Rajendran, Aravind Sivasubramanian, Santanu Kar Mahapatra
, RSC Adv.
, 2016
, 6
, 61777
- Jacalin-capped silver nanoparticles minimize the dosage use of the anticancer drug, shikonin derivatives, against human chronic myeloid leukemia. Khan Behlol Ayaz Ahmed, Santanu Kar Mahapatra, Mamilla R. Charan Raja, Shankar Subramaniam, Megarajan Sengan, Narendran Rajendran, Sandeep Kumar Das, Kuntal Haldar, Somenath Roy, Aravind Sivasubramanian, Veerappan Anbazhagan
, RSC Adv.
, 2016
, 6
, 18980
- Shikonin-mediated up-regulation of miR-34a and miR-202 inhibits retinoblastoma proliferation. Yan Su, Shiyou Lu, Jincun Li, Liya Deng
, Toxicol. Res.
, 2018
, 7
, 907